Genetic testing advances anticipatory medicine in Argentina

Advancements in genetic testing are shifting medical paradigms toward anticipatory medicine, focusing on prevention rather than just treatment. Researchers are now able to read the 3 billion letters of human DNA to identify more than 600 genetic diseases and personalize healthcare based on individual biological maps.

Adrián Turjanski, a CONICET researcher and scientific director of Gen360, led a team that developed Argentina’s first genetic risk test. This technology allows for the identification of predispositions to conditions such as glaucoma, cardiovascular risks, and certain cancers up to ten years earlier than standard guidelines.

Another significant development is pharmacogenomics, which uses genetic analysis to determine how different bodies metabolize active ingredients. This field aims to optimize medical treatments by adjusting exact dosages, avoiding adverse effects, and increasing economic efficiency by selecting the correct treatment from the start.